Nelson, John R.

Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial

Budoff, M. J., Bhatt, D. L., Kinninger, A., Lakshmanan, S., Muhlestein, J. B., Le, V. T., May, H. T., Shaikh, K., Shekar, C., Roy, S. K., et al. (2020) · European Heart Journal

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 446

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis

Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 175

Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography

Lakshmanan, S., Shekar, C., Kinninger, A., Dahal, S., Onuegbu, A., Cai, A. N., Hamal, S., Birudaraju, D., Roy, S. K., Nelson, J. R., et al. (2020) · Cardiovascular Research

Cardiac Imaging and DiagnosticsFatty Acid Research and Health

Cited by 42

History and future of omega-3 fatty acids in cardiovascular disease

Sperling, L. S., & Nelson, J. R. (2016) · Current Medical Research and Opinion

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 34

Differentiating EPA from EPA/DHA in cardiovascular risk reduction

Toth, P. P., Chapman, M. J., Parhofer, K. G., & Nelson, J. R. (2022) · American Heart Journal Plus: Cardiology Research and Practice

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 33

Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?

Nelson, J. R., True, W. S., Le, V., & Mason, R. P. (2017) · Postgraduate Medicine

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 27

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

Le, V. T., Knight, S., Watrous, J. D., Najhawan, M., Dao, K., McCubrey, R. O., Bair, T. L., Horne, B. D., May, H. T., Muhlestein, J. B., et al. (2023) · Frontiers in Cardiovascular Medicine

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 18

EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis

Sheppard, J. P., Lakshmanan, S., Dahal, S., Roy, S. K., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2022) · JACC: Cardiovascular Imaging

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 7

Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality

Sheppard, J. P., Palatnic, L., Lakshmanan, S., Drago, T., Bhogal, J., Roy, S. K., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2025) · JACC: Advances

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 3

EFFECTS OF PURIFIED EICOSAPENTAENOIC ACID VERSUS MIXED EICOSAPENTAENOIC/DOCOSAHEXAENOIC ACID ON CARDIOVASCULAR MORTALITY: META-ANALYSIS OF RANDOMIZED CLINICAL ENDPOINT TRIALS

Sheppard, J. P., Palatnic, L., Lakshmanan, S., Drago, T., Bhogal, J., Roy, S., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2024) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 2

Abstract 10905: Relationship of Eicosapentaenoic Acid and Docosahexaenoic Acid Dosage to Plaque Progression in Patients With Coronary Atherosclerosis Receiving Statin and Polyunsaturated Fatty Acid Therapy

Sheppard, J. P., Lakshmanan, S., Roy, S. K., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2022) · Circulation

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 1